ALSO NOTED: Transgene looks for vaccine partner; Shortage of rabies vaccine develops; and much more...
New vaccine/chemo combo effective in cancer study
New trial data shows that the combination of a chemotherapy drug and a new vaccine significantly prolonged the survival of patients with glioblastoma, the aggressive brain cancer that now afflicts
Researchers have begun human studies of a new vaccine that is designed to block or reverse type 1 diabetes. A team at Children's Hospital in Pittsburgh is loading microspheres with nucleic acid. In
Emergent buys Protein Sciences in $75M deal
Emergent BioSolutions has inked a deal to buy 25-year-old Protein Sciences for $75 million or more. Protein Sciences has been developing a new flu vaccine, FluBlok, relying on a new method that grows
Bavarian Nordic launches early trial for HIV vaccine
Denmark's Bavarian Nordic has launched a Phase I/II trial of an experimental HIV vaccine. Safety data from the study is expected by the end of this year with immunogenicity data following in the
SPOTLIGHT: Analyst lengthens timeline for Cervarix
ALSO NOTED: Progress on cancer vaccine; Big shoe maker adds vaccines; and much more...
The general prognosis for anyone diagnosed with malignant glioma is poor. The most common form is glioblastoma multiforme, which swiftly dispatches cancer cells throughout the brain. Patients
Prostate cancer vaccine performs well in early trial
An early-stage trial of an experimental prostate cancer vaccine demonstrated that it was safe and also generated an immune response among a large percentage of the volunteers in the study. A total of
An experimental vaccine developed at the University of Rochester Medical Center prevented the build-up of amyloid plaques in the brains of mice engineered to develop an aggressive form of Alzheimer's
The antiviral Relenza has won a battle over Tamiflu in the competition for government contracts from governments anxious about a possible bird flu epidemic. New research published in Nature
SPOTLIGHT: Virus hunters track flu virus to source
ALSO NOTED: Flu viruses more resistant; meningitis vaccine successful in trial; and much more...
Vaccine Market Experts told a meeting of the Infectious Diseases Society of America that flu viruses are growing increasingly resistant to antivirals, with Europe seeing some of the greatest
Allergy Therapeutics shares spike on late-stage data
Shares of the UK's Allergy Therapeutics surged on the news that its experimental hay fever vaccine--Pollinex Quattro--demonstrated positive results in a crucial Phase III study, which they say was
Novartis touts mid-stage results for MenB
Novartis says that a mid-stage study of its MenB vaccine demonstrated broad protection from meningococcal B infections in infants. Researchers tracked positive results starting with three
GlaxoSmithKline has released new Cervarix data that demonstrates the vaccine's ability to generate a high and sustained level of antibodies to neutralize the two most prevalent strains of cervical
Vaccine makers to produce record amount of flu jab
The five key vaccine makers say they plan to produce a record 143 million doses of flu vaccine for the U.S. market next season, which should be enough to satisfy demand. Manufacturers delivered 140
SPOTLIGHT: Intercell to acquire Iomai
Austria's Intercell is buying Iomai for $189 million in cash and stock. The deal will add Iomai's patch to prevent traveler's diarrhea and an adjuvant for bird flu vaccine that has produced
ALSO NOTED: Korea blueprints bird flu vaccine factory;HIV researchers vow to pursue vaccine; and much more...
Vaccine Market South Korea says it will build a bird flu vaccine factory next year. And the country says it will stockpile enough Tamiflu to be able to treat 10 million people in the event of a
The headlines may have died down in recent months, but bird flu experts say that the threat of a global pandemic has actually been growing. The World Health Organization outlined the spread of the